MultiPort Microcapillary Needle for ICSI
Assisted Reproductive Technology (IVF)
DevelopmentActive
Key Facts
About AkriVita
AkriVita is a private, pre-revenue medical device company founded in 2019 and headquartered in San Diego, California. It has developed a proprietary platform for 3D-printing silica-based microcapillary needles with innovative features like a MultiPort design and sealed fine-point tips to address common industry pain points such as needle clogging, inconsistent delivery, and poor visibility. Targeting the dermatology and broader life sciences sectors, AkriVita's value proposition centers on accelerating biomedical research and improving clinical outcomes through superior precision and customization in microinjection tools.
View full company profile